Exploring NUP62's role in cancer progression, tumor immunity, and treatment response: insights from multi-omics analysis.

Front Immunol · 2025 · PMC11911477 · PMID 40098960

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

We noted a decreasing trend in the expression level of NUP62 in testicular cancer tissues, which contrasts with the upregulation of NUP62 expression in most cancers.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.